nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation
|
Brekman, Angelika |
|
2011 |
13 |
1 |
|
artikel |
2 |
Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors
|
Mao, Jun J |
|
2011 |
13 |
1 |
|
artikel |
3 |
Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry
|
Smith, Letitia D |
|
2011 |
13 |
1 |
|
artikel |
4 |
During hormone depletion or tamoxifen treatment of breast cancer cells the estrogen receptor apoprotein supports cell cycling through the retinoic acid receptor α1 apoprotein
|
Salazar, Marcela D |
|
2011 |
13 |
1 |
|
artikel |
5 |
Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers
|
Xu, Huiling |
|
2011 |
13 |
1 |
|
artikel |
6 |
Genetic variation in the genome-wide predicted estrogen response element-related sequences is associated with breast cancer development
|
Yu, Jyh-Cherng |
|
2011 |
13 |
1 |
|
artikel |
7 |
Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer
|
Li, Yuqing |
|
2011 |
13 |
1 |
|
artikel |
8 |
Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth
|
Yan, Li Xu |
|
2011 |
13 |
1 |
|
artikel |
9 |
p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients
|
Bourdon, Jean-Christophe |
|
2011 |
13 |
1 |
|
artikel |
10 |
Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer
|
Arendt, Lisa M |
|
2011 |
13 |
1 |
|
artikel |
11 |
Proliferation-associated POU4F2/Brn-3b transcription factor expression is regulated by oestrogen through ERα and growth factors via MAPK pathway
|
Ounzain, Samir |
|
2011 |
13 |
1 |
|
artikel |
12 |
Quantification and clinical relevance of gene amplification at chromosome 17q12-q21 in human epidermal growth factor receptor 2-amplified breast cancers
|
Lamy, Pierre-Jean |
|
2011 |
13 |
1 |
|
artikel |
13 |
Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study
|
Le Calvez-Kelm, Florence |
|
2011 |
13 |
1 |
|
artikel |
14 |
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals
|
Kuusisto, Kirsi M |
|
2011 |
13 |
1 |
|
artikel |
15 |
α-TEA cooperates with chemotherapeutic agents to induce apoptosis of p53 mutant, triple-negative human breast cancer cells via activating p73
|
Tiwary, Richa |
|
2011 |
13 |
1 |
|
artikel |
16 |
The expression of the ubiquitin ligase SIAH2 (seven in absentia homolog 2) is mediated through gene copy number in breast cancer and is associated with a basal-like phenotype and p53 expression
|
Chan, Peter |
|
2011 |
13 |
1 |
|
artikel |
17 |
The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen
|
Fox, Stephen B |
|
2011 |
13 |
1 |
|
artikel |
18 |
α-Tocopheryloxyacetic acid: a novel chemotherapeutic that stimulates the antitumor immune response
|
Hahn, Tobias |
|
2011 |
13 |
1 |
|
artikel |
19 |
Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen
|
Brennan, Donal J |
|
2011 |
13 |
1 |
|
artikel |
20 |
Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) mice
|
Ladjemi, Maha Z |
|
2011 |
13 |
1 |
|
artikel |